Market Insights:
Single photon emission computed tomography (SPECT) is a non-invasive nuclear medicine tomographic imaging technique that uses gamma rays to provide 3D information about internal organs. This system uses a radioactive substance and a special camera to create 3-D pictures that display the blood flow to tissues and organs, thereby assisting doctors in diagnosing or monitoring brain disorders, bone disorders, and heart problems. The SPECT scan integrates two technologies: computed tomography (C.T.) and a radioactive material (tracer). Globally growing geriatric populations, combined with an increase in the prevalence of chronic diseases, are driving the demand for SPECT systems. Furthermore, technological developments in SPECT systems, the development of new radiotracers, increasing investments for the advancement of diagnostic imaging centers, and increasing awareness among people about the technology are expected to assist in the market’s growth. On the contrary, factors such as the requirement of massive capital, the presence of alternatives like scintigraphy and positron emission tomography (PET), high operation costs, and an immature reimbursement structure are anticipated to limit the utilization of the SPECT technique over the forecast period.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
The standalone SPECT systems are gaining popularity around the world and are thus expected to grow at a healthy rate during the forecast period. Based on application, the oncology segment is expected to dominate the market over the next nine years owing to the growing prevalence of cancer across the world. Higher adoption or utilization of the SPECT technique in hospitals will place the hospital segment in the lead.
North America is likely to hold a large chunk of the market due to the presence of major market participants, sophisticated healthcare infrastructure, and the comparatively higher adoption of advanced nuclear medicine tomographic imaging techniques in the U.S. and Canada. Asia Pacific will experience the fastest market growth in the near future, owing to an aging population, an increase in the incidence of chronic diseases, increased awareness of techniques and increased healthcare spending in China, India, and Japan.
The global single photon emission computed tomography market is classified as follows:
Global Single Photon Emission Computed Tomography Market by Product Type, 2016-2026 (in millions of U.S. dollars)
- Hybrid SPECT Systems
- Standalone SPECT systems
Global Single Photon Emission Computed Tomography Market by Application (US$ Mn), 2016-2026
- Oncology
- Cardiology
- Neurology
- Others
Global Single Photon Emission Computed Tomography Market, by End User, 2016–2026 (US$ Mn)
- Hospitals
- Diagnostic Imaging Centers
- Academic and Research Centers
- Others
Global Single Photon Emission Computed Tomography Market by Geography (US$ Mn), 2016-2026
- North America
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Key players identified in the global single photon emission computed tomography market include:
- G.E. Healthcare
- Philips Healthcare
- Siemens Healthineers
- Digirad Corporation
- Bruker Corporation
- NuCare Inc.
- PubMed
- surgical GmbH
- DDD-Diagnostic A/S
- Mediso Ltd.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
This report offers the following:
- Comprehensive overview of the global single photon emission computed tomography market, including the current and future market dynamics.
- Elucidation of each market segment based on recent product approvals, launches, and current and anticipated market dynamics
- Company profiles and competitive landscape of the leaders operating in the single photon emission computed tomography market, comprising key products, operating business areas, financial analysis, and recent strategic developments
